2025 AAMDSIF Bone Marrow Failure Summit: Translating Science to Advance Patient Outcomes
Since it was founded in 1983, AAMDSIF has partnered with clinicians and researchers to translate the latest knowledge of bone marrow failure conditions to advance patient outcomes. The 2025 Bone Marrow Failure Summit will feature engaging panels on aplastic anemia, PNH, MDS, MPN and AML. Each session will include presentations by thought leaders followed by moderated panel discussion. Topics will include the most noteworthy developments in standards of care, translational science, bone marrow transplant and GVHD, clinical trials, and predictions for the future treatment landscape.
This Summit is a unique forum that focuses on recent advances in the field and fosters robust debate both during and between the sessions. Researchers are invited to submit abstracts on innovative bone marrow failure research for the poster session on Thursday evening.
For New Investigators, the Summit is an especially rare opportunity to interact with international bone marrow failure experts. Travel grants are available for New Investigators to attend the program.
Poster Session: Abstracts summarizing new, ongoing, or updated research in bone marrow failure may be submitted by February 3, 2025. Apply here.
Travel Support for New Investigators: Limited Travel support is available. Apply here.
